miCure Therapeutics is a leading company in the field of RNA interference that was established in 2013 by a team of experienced biotech investors and entrepreneurs. Originally based in Rehovot, Israel, the company is founded on the robust scientific discoveries made by leading scientists of the Weizmann Institute for Science, where a deep understanding of the biology behind microRNAs involvement in central nervous system (CNS) related disorders, was gained